Subscribe to Journal
Get full journal access for 1 year
only $41.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Rothstein MA. Time to end the use of genetic test results in life insurance underwriting. J Law Med Ethics. 2018;46:794–801.
National Human Genome Research Institute. Genome Statute and Legislation Database. 2020. https://www.genome.gov/about-genomics/policy-issues/Genome-Statute-Legislation-Database.
American Medical Association. Genetic discrimination: a report of the American Medical Association Council on Science and Public Health. 2013. Chicago: American Medical Association; 2013.
Amendola LM, Robinson JO, Hart R, et al. Why patients decline genomic sequencing studies: experiences from the CSER Consortium. J Genet Couns. 2018;27:1220–1227.
Prince AER. Political economy, stakeholder voices, and saliency: lessons from international policies regulating insurer use of genetic information. J Law Biosci. 2019;5:461–494.
Joly Y, Feze IN, Song L, Knoppers BM. Comparative approaches to genetic discrimination: chasing shadows? Trends Genet. 2017;33:299–302.
American Council of Life Insurers. Summary of 2020 legislative trends specific to risk classification topics. 2020. https://www.acli.com/-/media/ACLI/Files/Events/MED2020/RiskClassificationIssuesOverviewUpdateFebruary2020.ashx?la=en.
Canadian Institute of Actuaries. Statement on genetic testing and insurance, Canadian Institute of Actuaries, Ottawa. 2014. https://www.cia-ica.ca/docs/default-source/2014/214073e.pdf.
Macdonald A, Yu F. The impact of genetic information on the insurance industry: conclusions from the ‘bottom-up’ modelling programme. ASTIN Bull. 2011;41:343–376.
Barlow-Stewart K, Liepins M, Doble A, Otlowski M. How are genetic test results being used by Australian life insurers? Eur J Hum Genet. 2018;26:1248–1256.
This work was funded by the National Human Genome Research Institute of the National Institutes of Health under award number R00HG008819 (A.E.R.P.).
A.C.F.L. has <$10,000 stock in Fabric Genomics. R.C.G. receives compensation for advising the following companies: AIA, Applied Therapeutics, Grail, Humanity, SavvySherpa, Wamberg Advisors; and is cofounder of Genome Medical, Inc, a technology and services company providing genetics expertise to patients, providers, employers, and care systems. A.E.R.P. declares no conflicts of interest. Dr. Green receives compensation for advising the following companies: AIA, SavvySherpa, Verily, Wamberg; and is co-founder of Genome Medical, Inc, a technology and services company providing genetics expertise to patients, providers, employers and care systems.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Lewis, A.C.F., Green, R.C. & Prince, A.E.R. Long-awaited progress in addressing genetic discrimination in the United States. Genet Med (2020). https://doi.org/10.1038/s41436-020-01002-y